Skip to main content
. 2022 Mar 9;16(3):350–354. doi: 10.1016/j.pcd.2022.03.004

Table 1.

Patients’ characteristics.

Subjects (n) 323
Average age (years) 63.1 ± 13.1
Number %
Male (n) 212 65.6
Female (n) 111 34.4
Type 1 diabetes 24 7.4
Type 2 diabetes 291 90.1
Other type of diabetes 8 2.5
Diabetes medication
Biguanide 192 59.4
Thiazolidine 2 0.6
α-Glucosidase inhibitor 20 6.2
SGLT2 inhibitor 111 34.4
DPP4 inhibitor 180 55.7
GLP-1 receptor agonist 34 10.5
Sulfonylurea 47 14.6
Glinide 22 6.8
Insulin 93 28.8